Diabetes Monitoring Devices Market Synopsis:
Diabetes Monitoring Devices Market Size Was Valued at USD 13.43 Billion in 2023, and is Projected to Reach USD 27.41 Billion by 2032, Growing at a CAGR of 8.25% From 2024-2032.
Diabetes Monitoring Devices Market means the industry that deals in products that help in diagnosis and/or management of diabetes. Blood glucose meters, CGM and insulin delivery devices are among necessary tools patients need for controlling their blood glucose levels. This is because the number of people suffering from diabetes increases with time all over the world hence the need for a better and efficient method of monitoring the condition has led to developments in technology as well as bringing new products in the market.
The global Diabetes Monitoring Devices Market is set to experience rapid growth because of the increasing incidence of diabetes. Currently, there were about 537 million adults living with diabetes in 2021 – according to the IDF – and the number is bound to grow even further. Diabetes mellitus type 2 has continued to rise and, with it, the need for proper monitoring solutions to help manage blood glucose concentrations and envisage potential complications. Other factors that have boosted demand for monitoring devices in individuals with diabetes are a growing sensitization to the illness and enhanced knowledge of its necessary management.
Trends are identified as one of the key factors that affect the Revenue of the Diabetes Monitoring Devices Market, which has been influenced by technological developments. Technological advancements like systems like CGM and smart ID devices in managing diabetes have advanced with some accuracy and efficiency. Smartphone connected wearable technologies are becoming widespread; patients are now able to monitor the real-time glucose level measured by the device and share data with the doctor. Not only do these developments provide increased patient accessibility, but also higher rates of efficiency translate into better health and increased market demand.
Diabetes Monitoring Devices Market Trend Analysis:
The increasing adoption of smart and connected devices.
- One of the driving facts about the Diabetes Monitoring Devices Market is the integration of smart and connected devices. For a long time, diabetes management has been focusing on monitoring procedures that have undergone a major shift due to the incorporation of IoT technology. Commercial devices also permit patients to connect their handhelds with mobile programs, thus achieving total view of glucose amounts, medication, and foodstuff. Such threats promote health literacy as patients get to access information and timely notifications that assist them to comprehend their therapies.
- The second major trend is the shift toward individualized approaches to diabetes treatment hits the spot. Device makers are creating devices adapted to the specific patients with a view to their daily routine, physical activity, and food intake. This concept helps improve compliance to the treatments and expand the satisfaction of the patients. Since patient-centricity is becoming more prevalent in today’s healthcare management systems, the need for specialized diabetes tracking tools cannot but rise.
The expanding geriatric population.
- The rising prevalence of diabetes along with the ageing population across the global geography poses risks as well as a major opportunity for the Diabetes Monitoring Devices Market. Diabetes management becomes a massive concern as people age necessitating better and enhanced monitoring tools for this population. Any firm that is able to design small, comfortable, and particularly informational machines and equipment for the elderly patients has the market ready for consumption. Also, to the integration of telehealth solutions in diabetes management devices can help people with this disease to have access to care, any again contributing to the market development.
- Asia Pacific and Latin AMericas remain promising markets for expansion because they are relatively new players in the global arena. Due to improved standard of living, inclination towards better health care, and booming diabetic population in these regions, there is huge market for cost effective diabetic management solutions. Businesses that positioning themselves in these markets and directing their products according to local requirements can provide a significant part of the continuously increasing diabetes monitoring devices market.
Diabetes Monitoring Devices Market Segment Analysis:
Diabetes Monitoring Devices Market Segmented on the basis of type, application and end user.
By Type, Blood Glucose Meters segment is expected to dominate the market during the forecast period
- The Diabetes Monitoring Devices Market is categorized based on the type of device and includes different products which play important roles in diabetes management. SMBGs are the most common type of home use glucometers, they enable patients to monitor the disease on their own without the need for professional help. CGM systems give real time glucose value and pattern throughout the day, which is more beneficial than just knowing random glucose value, and which allows for early interventions if necessary. Reusable insulin pens and insulin pump represent major types of insulin delivery devices to deliver accurate and convenient dosages of insulin. Others devices in this segment might be auxiliary like lancets, test strips, and computer applications helping in diabetes management addressing more to a great approach to managing diabetes.
By Technology, Wearable Devices segment expected to held the largest share
- The Diabetes Monitoring Devices Market is categorized based on the technology applied in three main types that improve the diabetes management. SMBG devices are convention glucometers that give the patient an instantaneous blood glucose measurement for self-management from a fingerstick blood sample. Mobile devices for diabetes, for example smart watches and CGMs give the benefit of monitoring glucose levels over time, further they provide integration with an associated mobile app to give real time updates. Another and rarer form of Augmentation is through implantation of devices that more frequently directly record the glucose levels of blood within the body and relay the information to the patients themselves and the healthcare providers as needed.
Diabetes Monitoring Devices Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- Diabetes Monitoring Devices Market is dominated more by North America with around 40 % market share of the global market. Such dominance is explained by higher levels of diagnosed diabetes, well-developed health care systems, and favourable reimbursement rates for diabetes care products. The research a development environment and the market presence of various key players also contribute to strengthening the regions dominance in the market.
- Moreover, North America offers a good distribution channel network and high customer awareness of diabetic management. From the guidelines more involvement of the patient is observed on the use of technology, in particular smart apps and telemedicine in diabetes management and urge the use of monitoring devices. For this reason, the Diabetes Monitoring Devices Market is expected to remain dominated by North America for the near future.
Active Key Players in the Diabetes Monitoring Devices Market:
- Abbott Laboratories (United States)
- Medtronic plc (Ireland)
- Dexcom, Inc. (United States)
- Roche Diabetes Care (Switzerland)
- Johnson & Johnson (United States)
- Ascensia Diabetes Care (Switzerland)
- Becton, Dickinson and Company (United States)
- Sanofi (France)
- Ypsomed AG (Switzerland)
- Siemens Healthineers (Germany)
- Other Active Players
Diabetes Monitoring Devices Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 13.43 Billion |
Forecast Period 2024-32 CAGR: |
8.25% |
Market Size in 2032: |
USD 27.41 Billion |
Segments Covered: |
By Type |
|
|
By Technology |
|
||
End User |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Diabetes Monitoring Devices Market by Device Type
4.1 Diabetes Monitoring Devices Market Snapshot and Growth Engine
4.2 Diabetes Monitoring Devices Market Overview
4.3 Blood Glucose Meters
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Blood Glucose Meters: Geographic Segmentation Analysis
4.4 Continuous Glucose Monitoring (CGM) Systems
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Continuous Glucose Monitoring (CGM) Systems: Geographic Segmentation Analysis
4.5 Insulin Delivery Devices
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Insulin Delivery Devices: Geographic Segmentation Analysis
4.6 Other Devices
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Other Devices: Geographic Segmentation Analysis
Chapter 5: Diabetes Monitoring Devices Market by Technology
5.1 Diabetes Monitoring Devices Market Snapshot and Growth Engine
5.2 Diabetes Monitoring Devices Market Overview
5.3 Self-Monitoring Blood Glucose (SMBG)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Self-Monitoring Blood Glucose (SMBG): Geographic Segmentation Analysis
5.4 Wearable Devices
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Wearable Devices: Geographic Segmentation Analysis
5.5 Implantable Devices)
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Implantable Devices): Geographic Segmentation Analysis
5.6
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 : Geographic Segmentation Analysis
Chapter 6: Diabetes Monitoring Devices Market by End User
6.1 Diabetes Monitoring Devices Market Snapshot and Growth Engine
6.2 Diabetes Monitoring Devices Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation Analysis
6.4 Homecare Settings
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Homecare Settings: Geographic Segmentation Analysis
6.5 Diagnostic Centers
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Diagnostic Centers: Geographic Segmentation Analysis
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Diabetes Monitoring Devices Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ABBOTT LABORATORIES (UNITED STATES)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 MEDTRONIC PLC (IRELAND)
7.4 DEXCOM INC. (UNITED STATES)
7.5 ROCHE DIABETES CARE (SWITZERLAND)
7.6 JOHNSON & JOHNSON (UNITED STATES)
7.7 ASCENSIA DIABETES CARE (SWITZERLAND)
7.8 BECTON
7.9 DICKINSON AND COMPANY (UNITED STATES)
7.10 SANOFI (FRANCE)
7.11 YPSOMED AG (SWITZERLAND)
7.12 SIEMENS HEALTHINEERS (GERMANY)
7.13 OTHER ACTIVE PLAYERS
Chapter 8: Global Diabetes Monitoring Devices Market By Region
8.1 Overview
8.2. North America Diabetes Monitoring Devices Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Device Type
8.2.4.1 Blood Glucose Meters
8.2.4.2 Continuous Glucose Monitoring (CGM) Systems
8.2.4.3 Insulin Delivery Devices
8.2.4.4 Other Devices
8.2.5 Historic and Forecasted Market Size By Technology
8.2.5.1 Self-Monitoring Blood Glucose (SMBG)
8.2.5.2 Wearable Devices
8.2.5.3 Implantable Devices)
8.2.5.4
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospitals
8.2.6.2 Homecare Settings
8.2.6.3 Diagnostic Centers
8.2.6.4 Others
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Diabetes Monitoring Devices Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Device Type
8.3.4.1 Blood Glucose Meters
8.3.4.2 Continuous Glucose Monitoring (CGM) Systems
8.3.4.3 Insulin Delivery Devices
8.3.4.4 Other Devices
8.3.5 Historic and Forecasted Market Size By Technology
8.3.5.1 Self-Monitoring Blood Glucose (SMBG)
8.3.5.2 Wearable Devices
8.3.5.3 Implantable Devices)
8.3.5.4
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospitals
8.3.6.2 Homecare Settings
8.3.6.3 Diagnostic Centers
8.3.6.4 Others
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Diabetes Monitoring Devices Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Device Type
8.4.4.1 Blood Glucose Meters
8.4.4.2 Continuous Glucose Monitoring (CGM) Systems
8.4.4.3 Insulin Delivery Devices
8.4.4.4 Other Devices
8.4.5 Historic and Forecasted Market Size By Technology
8.4.5.1 Self-Monitoring Blood Glucose (SMBG)
8.4.5.2 Wearable Devices
8.4.5.3 Implantable Devices)
8.4.5.4
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospitals
8.4.6.2 Homecare Settings
8.4.6.3 Diagnostic Centers
8.4.6.4 Others
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Diabetes Monitoring Devices Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Device Type
8.5.4.1 Blood Glucose Meters
8.5.4.2 Continuous Glucose Monitoring (CGM) Systems
8.5.4.3 Insulin Delivery Devices
8.5.4.4 Other Devices
8.5.5 Historic and Forecasted Market Size By Technology
8.5.5.1 Self-Monitoring Blood Glucose (SMBG)
8.5.5.2 Wearable Devices
8.5.5.3 Implantable Devices)
8.5.5.4
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospitals
8.5.6.2 Homecare Settings
8.5.6.3 Diagnostic Centers
8.5.6.4 Others
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Diabetes Monitoring Devices Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Device Type
8.6.4.1 Blood Glucose Meters
8.6.4.2 Continuous Glucose Monitoring (CGM) Systems
8.6.4.3 Insulin Delivery Devices
8.6.4.4 Other Devices
8.6.5 Historic and Forecasted Market Size By Technology
8.6.5.1 Self-Monitoring Blood Glucose (SMBG)
8.6.5.2 Wearable Devices
8.6.5.3 Implantable Devices)
8.6.5.4
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospitals
8.6.6.2 Homecare Settings
8.6.6.3 Diagnostic Centers
8.6.6.4 Others
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Diabetes Monitoring Devices Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Device Type
8.7.4.1 Blood Glucose Meters
8.7.4.2 Continuous Glucose Monitoring (CGM) Systems
8.7.4.3 Insulin Delivery Devices
8.7.4.4 Other Devices
8.7.5 Historic and Forecasted Market Size By Technology
8.7.5.1 Self-Monitoring Blood Glucose (SMBG)
8.7.5.2 Wearable Devices
8.7.5.3 Implantable Devices)
8.7.5.4
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospitals
8.7.6.2 Homecare Settings
8.7.6.3 Diagnostic Centers
8.7.6.4 Others
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Diabetes Monitoring Devices Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 13.43 Billion |
Forecast Period 2024-32 CAGR: |
8.25% |
Market Size in 2032: |
USD 27.41 Billion |
Segments Covered: |
By Type |
|
|
By Technology |
|
||
End User |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Frequently Asked Questions :
The forecast period in the Diabetes Monitoring Devices Market research report is 2024-2032.
Abbott Laboratories (United States), Medtronic plc (Ireland), Dexcom, Inc. (United States), Roche Diabetes Care (Switzerland), Johnson & Johnson (United States), Ascensia Diabetes Care (Switzerland), Becton, Dickinson and Company (United States), Sanofi (France), Ypsomed AG (Switzerland), Siemens Healthineers (Germany). and Other Active Players.
The Diabetes Monitoring Devices Market is segmented into by Device Type (Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Systems, Insulin Delivery Devices, Other Devices), Technology (Self-Monitoring Blood Glucose (SMBG), Wearable Devices, Implantable Devices), End User (Hospitals, Homecare Settings, Diagnostic Centers, Others). By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Diabetes Monitoring Devices Market means the industry that deals in products that help in diagnosis and/or management of diabetes. Blood glucose meters, CGM and insulin delivery devices are among necessary tools patients need for controlling their blood glucose levels. This is because the number of people suffering from diabetes increases with time all over the world hence the need for a better and efficient method of monitoring the condition has led to developments in technology as well as bringing new products in the market.
Diabetes Monitoring Devices Market Size Was Valued at USD 13.43 Billion in 2023, and is Projected to Reach USD 27.41 Billion by 2032, Growing at a CAGR of 8.25% From 2024-2032.